Under construction – not a live service
Sign in
Not yet taking people in EgyptNo phase

Studying drug-resistant bacteria found in patients with leukemia

Tests bacteria resistant to carbapenem antibiotics in patients with acute myeloid leukemia.

Plain-language title generated from the registry record
Registry title: Molecular Characterization of Carbapenemase-Producing Enterobacterales

Key facts

Where
Sohag, EgyptSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 4 and 80 years old?

Source: NCT07116356, who can take part

Where in Egypt

  • Sohag university, Faculty of medicineSohag, EgyptNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Sohag University
Trial code
NCT07116356
Record updated
11 August 2025
Original description
Bacterial infections with carbapenem resistant pathogens are one of the major threats in immunocompromised patients, especially among cancer patients .Furthermore, Gram negative pathogens are becoming increasingly prevalent and have become an ongoing global health concern .Emergence of Gram-negative pathogens, especially Enterobacterales that avert many of the human defense mechanisms are alarmingly increasing and most of these pathogens are resistant to many of the in-use antibiotics including carbapenems .Read full original descriptionShow less

Molecular Characterization of Carbapenemase-Producing Enterobacterales Isolated From Clinical Samples in Egypt

Bacterial infections with carbapenem resistant pathogens are one of the major threats in immunocompromised patients, especially among cancer patients .Furthermore, Gram negative pathogens are becoming increasingly prevalent and have become an ongoing global health concern .Emergence of Gram-negative pathogens, especially Enterobacterales that avert many of the human defense mechanisms are alarmingly increasing and most of these pathogens are resistant to many of the in-use antibiotics including carbapenems .

Inclusion: All patients admitted to Sohag Oncology Center have different infections and isolated organism one of carbapenem resistant enterobacterales detected by antibiotic sensitivity test.

Exclusion: All patients admitted to Sohag Oncology Center having infections in different sites and isolated organisms are not one of enterobacterales and not carbapenem resistant.

ClinicalTrials.gov NCT07116356